DGCR8 and hepatocellular carcinoma: As a suppressor in hepatocellular carcinoma (HCC), METTL14 interacts with DGCR8 to promote the processing of pri-miR-126 via an m6A-dependent pattern, triggering the enhanced level of miR-126 which represses the tumor metastasis 115.